[ad_1]
The US Food and Drug Administration (FDA) has updated its medication recall list for hypertension to warn consumers of another voluntary recall of drugs for hypertension, the valsartan.
On Tuesday, Teva Pharmaceuticals launched another voluntary recall regarding combined valsartan tablets manufactured by Mylan India, including amlodipine-valsartan combination tablets and amlodipine-valsartan-hydrochlorothiazide combination tablets.
All of these drugs are recalled because of the possibility that they may be contaminated with N-nitrosodiethylamine (NDEA), an organic chemical used in the manufacture of liquid rocket fuel and classified as potentially carcinogenic to humans. .
These ongoing 2018 blood pressure reminders began in July when three pharmaceutical companies, including Teva Pharmaceuticals, began recalling drugs containing valsartan. With this reminder, Teva is now withdrawing all of its drugs from the Valsartan market in the US market.
Other drugs for hypertension have been recalled because they also contain traces of NDEA. In early November, another anti-hypertensive drug, irbesartan, was recalled, followed in mid-November by a voluntary booster of losartan potassium hydrochlorothiazide tablets, also prescribed to treat the condition. # 39; hypertension.
As with other medications recalled for valsartan, it is advisable to contact your health care provider while continuing to take the recalled medications. The sudden shutdown of such high blood pressure medication could cause other serious medical problems.
You will find a complete list of lots of Teva Pharmaceutical's hypertension medications recalled here.
Source link
